

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 31.24 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 25.08 | Oscillator | Neutral |
| Williams %R (14) | -79.93 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.61 (Hist -0.14) | Oscillator | Strong Sell |
| Average Directional Index (14) | 36.80 (+DI 11.9 / -DI 31.7) | Trend |
Current price $7.88
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 8, 24 | Needham |
| EMA 20 | 8.87 | MA | Strong Sell |
| SMA 20 | 9.15 | MA | Strong Sell |
| EMA 50 | 9.40 | MA | Strong Sell |
| SMA 50 | 9.68 | MA | Strong Sell |
| SMA 200 | 8.91 | MA | Strong Sell |
| maintain |
| Buy |
| Buy |
| May 10, 24 | Needham | maintain | Buy | Buy |
| Mar 8, 24 | Wedbush | maintain | Outperform | Outperform |
| Mar 7, 24 | Needham | maintain | Buy | Buy |
| Mar 7, 24 | Craig-Hallum | maintain | Hold | Hold |
| Aug 10, 23 | Needham | maintain | Buy | Buy |
| May 19, 23 | Wedbush | maintain | Outperform | Outperform |
| May 19, 23 | Benchmark | downgrade | Buy | Hold |
| May 18, 23 | Needham | maintain | Buy | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 425 | Oct 19, 2026 | 2026-10-19 16:22:43 | View |
| 8-K | Oct 19, 2026 | 2026-10-19 16:22:35 | View |
| 425 | Oct 6, 2026 | 2026-10-06 13:47:25 | View |
| 8-K | Oct 6, 2026 | 2026-10-06 13:47:09 | View |
| F-X | Oct 6, 2026 | 2026-10-06 09:45:45 | View |
| SC14D1F/A | Oct 6, 2026 | 2026-10-06 09:43:58 | View |
| 425 | Oct 6, 2026 | 2026-10-06 08:38:49 | View |
| 8-K | Oct 6, 2026 | 2026-10-06 08:37:53 | View |
| F-80 | Oct 6, 2026 | 2026-10-06 07:43:49 | View |
| 8-K | Oct 5, 2026 | 2026-10-02 18:26:26 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
CURLF's hostile Aurora bid adds uncertainty as revenues recover, but margin pressure, rising costs and intense competition keep investors cautious.
Curaleaf TodayCURLFCuraleaf$7.80 +0.17 (+2.26%) As of 02:38 PM Eastern52-Week Range$5.40▼$15.15Price Target$6.00Add to WatchlistCuraleaf Holdings, Inc. OTCMKTS: CURLF is aggressively maneuvering to absorb Aurora Cannabis Inc. NASDAQ: ACB, leveraging an estimated 217% ex-cash premium to force a shareholder reckoning and bypass an entrenched board.
New location brings the Company's Florida footprint to 80 stores and 190 nationwide STAMFORD, Conn., Oct. 20, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that Curaleaf Port Orange will begin welcoming patients on October 21, 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -0.17 | 0.05 | Beat 130.1% | $340.1M |
| May 5, 2026 | -0.24 | 0.27 | Beat 212.5% | $324.2M |
| Feb 26, 2026 | -0.24 | -0.15 | Beat 37.5% | $333.1M |
| Nov 5, 2025 | -0.21 | -0.18 | Beat 14.3% | $320.2M |
| Aug 6, 2025 | -0.21 | -0.18 | Beat 14.3% | $315.0M |
| May 8, 2025 | -0.21 | -0.21 | Beat 0.0% | $310.0M |
TTM vs. 5-year historical average (annual ratios)
| Metric | CURLF | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -57.4x | -17.6x · sector 20.7x | Discount |
| Forward P/E (FY26E) | 394.0x | EPS est. 0.02 | Discount |
| Price / Book | 2.4x | 2.6x | In line |
| Price / Sales | 1.4x | 2.5x | Discount |
| EV / EBITDA | 14.8x | 23.6x | Discount |
| Return on equity | -4.5% | — | Weak |
| Gross margin | 44.0% | 37.9% | Above hist. |
| Debt / Equity | 1.29 | 1.01 | Moderate |
| Piotroski / Altman Z | 5/9 | Z 0.36 | Distress |
Discounted cash flow model